{
    "nct_id": "NCT06898424",
    "title": "Effects of Concurrent Plant-Based Ketogenic Diet and Intermittent Fasting (Ketoflex 12/3) on the Clinical Progression of Early-to-Mid Stage Alzheimer's Dementia",
    "status": "COMPLETED",
    "last_update_time": "2025-03-27",
    "description_brief": "This study investigates the effects of the Ketoflex 12/3 diet on the clinical progression of early-to-mid stage Alzheimer's disease. The study evaluates cognitive function, metabolic changes, and overall health outcomes in participants following the Ketoflex 12/3 dietary protocol.",
    "description_detailed": "N/A",
    "phase": [
        "NA"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "PREVENTION",
    "results": null,
    "target_category": "N/A",
    "drug": [],
    "placebo": [],
    "explanation_target": [
        "Reason: The description and trial title indicate a dietary (behavioral) intervention \u2014 the Ketoflex 12/3 plant\u2011based ketogenic diet combined with intermittent fasting \u2014 intended to affect clinical progression and cognitive outcomes in early\u2011to\u2011mid Alzheimer\u2019s disease. The four provided categories are all drug/intervention types (biologic, small molecule, cognitive\u2011enhancer drug, or neuropsychiatric symptom drug). A diet is neither a biologic nor a small molecule drug, nor is it a labeled pharmacologic cognitive enhancer or neuropsychiatric drug, so it does not fit any of those four categories. \ue200cite\ue202turn0search1\ue202turn0search2\ue201",
        "Act: Key extracted details and supporting web references: \u2022 Intervention: Ketoflex 12/3 (plant\u2011based mildly ketogenic diet + nightly intermittent fasting). \ue200cite\ue202turn0search2\ue202turn0search6\ue201 \u2022 Trial registry / design: Interventional, randomized, parallel\u2011group behavioral intervention (NCT06898424) studying Ketoflex 12/3 vs usual diet with primary cognitive outcome (MMSE) at 6 months; enrollment ~60. \ue200cite\ue202turn0search1\ue202turn0search5\ue201 \u2022 Purpose/effects studied: cognitive function, metabolic changes, and overall health outcomes (aiming at clinical progression / prevention), not testing a drug molecule or biologic agent. \ue200cite\ue202turn0search0\ue202turn0search1\ue201",
        "Reflect: Classification check \u2014 because the intervention is a dietary/behavioral protocol (KetoFLEX 12/3 / Bredesen\u2011style diet) rather than a therapeutic drug or biologic, the trial does not map to any of the four drug\u2011focused categories. Therefore the correct output is 'N/A'. If you want a different taxonomy that includes non\u2011pharmacologic interventions (e.g., 'dietary intervention' or 'lifestyle intervention'), I can reclassify accordingly. Additional sources consulted: clinical trial listings and KetoFLEX 12/3 program pages describing the diet and its brain\u2011health rationale. \ue200cite\ue202turn0search1\ue202turn0search2\ue202turn0search0\ue201"
    ],
    "agent_type": "N/A",
    "explanation_agent": []
}